ADRM1 and cancer: Proteasome–ubiquitin receptor hRpn13/Adrm1 binds and activates deubiquitinatingenzyme Uch37/UCHL5 and is targeted by bis-benzylidine piperidone RA190, whichrestricts cancer growth in mice xenografts.